Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US6790837 | SCHERING | Ribavirin syrup formulations |
Apr, 2023
(11 months ago) | |
US6790837 (Pediatric) | SCHERING | Ribavirin syrup formulations |
Oct, 2023
(5 months ago) |
Market Authorisation Date: 29 July, 2003
Treatment: NA
Dosage: SOLUTION;ORAL